DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Cash Flow Statement
Cash Flow Statement
DaShenLin Pharmaceutical Group Co Ltd
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
14
|
0
|
0
|
0
|
66
|
0
|
0
|
0
|
40
|
0
|
0
|
0
|
19
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(539)
|
(565)
|
(581)
|
(539)
|
(622)
|
(590)
|
(661)
|
(701)
|
(679)
|
(682)
|
(740)
|
(681)
|
(776)
|
(783)
|
(825)
|
(851)
|
(847)
|
(863)
|
(882)
|
(890)
|
(898)
|
(917)
|
(904)
|
(967)
|
(939)
|
(978)
|
(1 119)
|
(1 138)
|
(1 108)
|
(1 229)
|
(1 254)
|
(1 366)
|
(1 268)
|
(1 320)
|
(1 385)
|
(1 217)
|
|
| Change in Working Capital |
(1 844)
|
(1 943)
|
(2 019)
|
(2 262)
|
(2 284)
|
(2 394)
|
(2 526)
|
(2 716)
|
(2 839)
|
(3 032)
|
(2 979)
|
(2 969)
|
(3 024)
|
(3 263)
|
(3 319)
|
(3 554)
|
(3 721)
|
(3 730)
|
(4 016)
|
(4 174)
|
(3 908)
|
(3 960)
|
(4 400)
|
(4 271)
|
(4 641)
|
(4 839)
|
(4 906)
|
(4 923)
|
(5 859)
|
(6 287)
|
(6 715)
|
(7 553)
|
(7 293)
|
(6 761)
|
(5 761)
|
(5 668)
|
|
| Cash from Operating Activities |
496
N/A
|
502
+1%
|
497
-1%
|
545
+10%
|
648
+19%
|
511
-21%
|
553
+8%
|
663
+20%
|
874
+32%
|
1 119
+28%
|
1 286
+15%
|
1 462
+14%
|
1 708
+17%
|
1 779
+4%
|
1 759
-1%
|
1 966
+12%
|
1 954
-1%
|
2 145
+10%
|
2 066
-4%
|
1 833
-11%
|
1 555
-15%
|
1 708
+10%
|
2 237
+31%
|
2 411
+8%
|
3 757
+56%
|
3 843
+2%
|
3 815
-1%
|
4 160
+9%
|
3 174
-24%
|
3 648
+15%
|
3 464
-5%
|
3 202
-8%
|
3 106
-3%
|
3 648
+17%
|
4 249
+16%
|
4 326
+2%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||||||||||||
| Capital Expenditures |
(307)
|
(327)
|
(394)
|
(427)
|
(669)
|
(718)
|
(739)
|
(781)
|
(554)
|
(506)
|
(434)
|
(290)
|
(501)
|
(554)
|
(530)
|
(536)
|
(792)
|
(859)
|
(969)
|
(1 151)
|
(1 295)
|
(1 325)
|
(1 210)
|
(1 151)
|
(1 035)
|
(1 314)
|
(1 968)
|
(2 104)
|
(1 797)
|
(1 599)
|
(1 829)
|
(1 714)
|
(1 476)
|
(1 259)
|
(416)
|
(404)
|
|
| Other Items |
(118)
|
(102)
|
(80)
|
(545)
|
(769)
|
(584)
|
(279)
|
276
|
237
|
94
|
(920)
|
(1 218)
|
(1 157)
|
(869)
|
(189)
|
65
|
(279)
|
(688)
|
(726)
|
(590)
|
327
|
172
|
162
|
126
|
(259)
|
(133)
|
(210)
|
(322)
|
(507)
|
(532)
|
(507)
|
(693)
|
(463)
|
(341)
|
(220)
|
(51)
|
|
| Cash from Investing Activities |
(425)
N/A
|
(428)
-1%
|
(474)
-11%
|
(972)
-105%
|
(1 437)
-48%
|
(1 302)
+9%
|
(1 018)
+22%
|
(505)
+50%
|
(317)
+37%
|
(411)
-30%
|
(1 354)
-229%
|
(1 508)
-11%
|
(1 659)
-10%
|
(1 423)
+14%
|
(720)
+49%
|
(471)
+35%
|
(1 071)
-127%
|
(1 547)
-44%
|
(1 695)
-10%
|
(1 740)
-3%
|
(968)
+44%
|
(1 152)
-19%
|
(1 048)
+9%
|
(1 025)
+2%
|
(1 294)
-26%
|
(1 447)
-12%
|
(2 178)
-51%
|
(2 426)
-11%
|
(2 303)
+5%
|
(2 130)
+8%
|
(2 336)
-10%
|
(2 407)
-3%
|
(1 939)
+19%
|
(1 600)
+18%
|
(636)
+60%
|
(454)
+29%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||||||||||||
| Net Issuance of Debt |
149
|
78
|
154
|
(51)
|
106
|
69
|
4
|
147
|
(162)
|
(115)
|
826
|
561
|
704
|
820
|
(203)
|
(34)
|
1 451
|
1 226
|
1 252
|
1 281
|
(77)
|
309
|
545
|
571
|
686
|
403
|
70
|
(41)
|
119
|
279
|
760
|
1 217
|
1 189
|
514
|
(605)
|
(929)
|
|
| Cash Paid for Dividends |
(160)
|
(162)
|
(158)
|
(22)
|
(21)
|
(22)
|
(247)
|
(263)
|
(263)
|
(261)
|
(273)
|
(254)
|
(253)
|
(251)
|
(305)
|
(334)
|
(333)
|
(333)
|
(531)
|
(530)
|
(534)
|
(540)
|
(445)
|
(417)
|
(420)
|
(437)
|
(639)
|
(656)
|
(605)
|
(684)
|
(455)
|
(454)
|
(753)
|
(800)
|
(785)
|
(767)
|
|
| Other |
23
|
32
|
42
|
977
|
976
|
978
|
968
|
10
|
(12)
|
(7)
|
(8)
|
(9)
|
(30)
|
(74)
|
(66)
|
(78)
|
92
|
(128)
|
(424)
|
(735)
|
(1 000)
|
(1 080)
|
(924)
|
(897)
|
(1 200)
|
(1 168)
|
(1 101)
|
(1 059)
|
(1 164)
|
(1 133)
|
(1 271)
|
(1 411)
|
(1 368)
|
(1 310)
|
(1 505)
|
(1 472)
|
|
| Cash from Financing Activities |
12
N/A
|
(52)
N/A
|
38
N/A
|
905
+2 274%
|
1 061
+17%
|
1 025
-3%
|
725
-29%
|
(106)
N/A
|
(437)
-313%
|
(383)
+12%
|
546
N/A
|
298
-45%
|
420
+41%
|
496
+18%
|
(573)
N/A
|
(445)
+22%
|
1 209
N/A
|
765
-37%
|
296
-61%
|
17
-94%
|
(1 612)
N/A
|
(1 311)
+19%
|
(824)
+37%
|
(744)
+10%
|
(934)
-26%
|
(1 202)
-29%
|
(1 671)
-39%
|
(1 756)
-5%
|
(1 649)
+6%
|
(1 539)
+7%
|
(966)
+37%
|
(649)
+33%
|
(932)
-44%
|
(1 596)
-71%
|
(2 895)
-81%
|
(3 167)
-9%
|
|
| Change in Cash | |||||||||||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
82
N/A
|
22
-73%
|
62
+177%
|
478
+674%
|
272
-43%
|
234
-14%
|
261
+11%
|
52
-80%
|
120
+129%
|
324
+171%
|
478
+47%
|
252
-47%
|
469
+87%
|
851
+81%
|
466
-45%
|
1 050
+125%
|
2 092
+99%
|
1 363
-35%
|
667
-51%
|
109
-84%
|
(1 025)
N/A
|
(755)
+26%
|
366
N/A
|
642
+76%
|
1 529
+138%
|
1 194
-22%
|
(34)
N/A
|
(22)
+34%
|
(779)
-3 376%
|
(21)
+97%
|
162
N/A
|
146
-10%
|
235
+61%
|
451
+92%
|
719
+59%
|
704
-2%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||||||||||||
| Free Cash Flow |
188
N/A
|
176
-7%
|
103
-41%
|
118
+14%
|
(21)
N/A
|
(207)
-900%
|
(186)
+10%
|
(118)
+37%
|
319
N/A
|
613
+92%
|
852
+39%
|
1 172
+38%
|
1 206
+3%
|
1 225
+2%
|
1 229
+0%
|
1 430
+16%
|
1 162
-19%
|
1 286
+11%
|
1 097
-15%
|
682
-38%
|
260
-62%
|
384
+48%
|
1 027
+168%
|
1 260
+23%
|
2 722
+116%
|
2 529
-7%
|
1 846
-27%
|
2 055
+11%
|
1 377
-33%
|
2 049
+49%
|
1 634
-20%
|
1 488
-9%
|
1 630
+10%
|
2 389
+47%
|
3 833
+60%
|
3 922
+2%
|
|